Ondas Holdings And 2 Other Stocks Under $1 Insiders Are Buying

The Dow Jones closed higher by around 2 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Innovative Food Holdings

• The Trade: Innovative Food Holdings, Inc. IVFH 10% owner JCP Investment Holdings, LLC acquired a total of 255,000 shares an average price of $0.69. To acquire these shares, it cost around $175,850.
• What’s Happening: The company posted GAAP net income of $0.134 million, or $0.003 per share for the third quarter.
• What Innovative Food Holdings Does: Innovative Food Holdings Inc through its subsidiaries is engaged in the distribution of perishables and specialty food products.

Ondas Holdings

• The Trade: Ondas Holdings Inc. ONDS 10% owner Joseph V Popolo acquired a total of 342,880 shares at an average price of $0.71. To acquire these shares, it cost around $243,582.
• What’s Happening: Ondas Holdings posted a narrower-than-expected quarterly loss.
• What Ondas Holdings Does: Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India.

Check This Out: Agilent Likely To Report Lower Q4 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

VolitionRx

• The Trade: VolitionRx Limited VNRX CEO - Volition Veterinary Salvatore Thomas Butera acquired a total of 10,000 shares at an average price of $0.81. The insider spent around $8,100 to buy those shares.
• What’s Happening: Cantor Fitzgerald recently maintained VolitionRX with an Overweight and raised the price target from $2.1 to $2.5.
• What VolitionRx Does: VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19.

Don’t forget to check out our premarket coverage here